Cargando…

Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?

Noninvasive low-intensity extracorporeal shockwave treatment (Li-ESWT) has been widely used to treat erection disorders. There is no clear information regarding either the selection of patients for the treatment or the treatment protocol. In this study, we aimed to investigate the efficacy of extrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ergün, Müslüm, Akyüz, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491027/
https://www.ncbi.nlm.nih.gov/pubmed/35042309
http://dx.doi.org/10.4103/aja2021105
_version_ 1784793206774300672
author Ergün, Müslüm
Akyüz, Osman
author_facet Ergün, Müslüm
Akyüz, Osman
author_sort Ergün, Müslüm
collection PubMed
description Noninvasive low-intensity extracorporeal shockwave treatment (Li-ESWT) has been widely used to treat erection disorders. There is no clear information regarding either the selection of patients for the treatment or the treatment protocol. In this study, we aimed to investigate the efficacy of extracorporeal shockwave therapy in diabetic patients with severe erectile dysfunction (International Index of Erectile Function-5 [IIEF-5] scores of 5 to 7). Sixty-three diabetes mellitus patients with erectile dysfunction having IIEF-5 scores of 5 to 7 and not showing a recovery of potency despite phosphodiesterase type 5 inhibitor therapy for the past 6 months were included in the study. The patients were evaluated based on their IIEF-5 scores and Erection Hardness Scale scores. The IIEF-5 score (mean ± standard deviation [s.d.]) increased from 5.29 ± 1.67 to 5.56 ± 1.85, with a difference of 0.27 ± 0.18 (P > 0.05). The Erection Hardness Scale scores (mean ± s.d.), on the other hand, increased from 1.46 ± 0.50 to 1.48 ± 0.50, with a difference of 0.02 ± 0 (P > 0.05). In conclusion, the response to phosphodiesterase type 5 inhibitors did not change after extracorporeal shockwave treatment in diabetes mellitus patients with severe erectile dysfunction (IIEF-5 scores of 5 to 7).
format Online
Article
Text
id pubmed-9491027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-94910272022-09-22 Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? Ergün, Müslüm Akyüz, Osman Asian J Androl Original Article Noninvasive low-intensity extracorporeal shockwave treatment (Li-ESWT) has been widely used to treat erection disorders. There is no clear information regarding either the selection of patients for the treatment or the treatment protocol. In this study, we aimed to investigate the efficacy of extracorporeal shockwave therapy in diabetic patients with severe erectile dysfunction (International Index of Erectile Function-5 [IIEF-5] scores of 5 to 7). Sixty-three diabetes mellitus patients with erectile dysfunction having IIEF-5 scores of 5 to 7 and not showing a recovery of potency despite phosphodiesterase type 5 inhibitor therapy for the past 6 months were included in the study. The patients were evaluated based on their IIEF-5 scores and Erection Hardness Scale scores. The IIEF-5 score (mean ± standard deviation [s.d.]) increased from 5.29 ± 1.67 to 5.56 ± 1.85, with a difference of 0.27 ± 0.18 (P > 0.05). The Erection Hardness Scale scores (mean ± s.d.), on the other hand, increased from 1.46 ± 0.50 to 1.48 ± 0.50, with a difference of 0.02 ± 0 (P > 0.05). In conclusion, the response to phosphodiesterase type 5 inhibitors did not change after extracorporeal shockwave treatment in diabetes mellitus patients with severe erectile dysfunction (IIEF-5 scores of 5 to 7). Wolters Kluwer - Medknow 2022-01-14 /pmc/articles/PMC9491027/ /pubmed/35042309 http://dx.doi.org/10.4103/aja2021105 Text en Copyright: ©The Author(s)(2022) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ergün, Müslüm
Akyüz, Osman
Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?
title Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?
title_full Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?
title_fullStr Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?
title_full_unstemmed Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?
title_short Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?
title_sort is li-eswt effective in diabetic patients with severe erectile dysfunction?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491027/
https://www.ncbi.nlm.nih.gov/pubmed/35042309
http://dx.doi.org/10.4103/aja2021105
work_keys_str_mv AT ergunmuslum islieswteffectiveindiabeticpatientswithsevereerectiledysfunction
AT akyuzosman islieswteffectiveindiabeticpatientswithsevereerectiledysfunction